Clarification of venlafaxine chemistry, pharmacology, and pharmacokinetics.
作者信息
Albano D, Amchin J
出版信息
Am J Health Syst Pharm. 1995 Jul 15;52(14):1573-4. doi: 10.1093/ajhp/52.14.1573.
PMID:7552908
Abstract
摘要
相似文献
1
Clarification of venlafaxine chemistry, pharmacology, and pharmacokinetics.文拉法辛的化学、药理学及药代动力学阐释。
Am J Health Syst Pharm. 1995 Jul 15;52(14):1573-4. doi: 10.1093/ajhp/52.14.1573.
2
Antidepressants.抗抑郁药
J Clin Psychiatry. 1997;58 Suppl 6:9-25.
3
Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.文拉法辛和奈法唑酮，两种药理特性不同的抗抑郁药。
Pharmacotherapy. 1997 May-Jun;17(3):511-30.
4
Venlafaxine marketed as antidepressant.文拉法辛作为抗抑郁药上市。
Am J Hosp Pharm. 1994 Jul 1;51(13):1606.
5
Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.
J Clin Psychopharmacol. 2010 Aug;30(4):473-4. doi: 10.1097/JCP.0b013e3181e5c0e4.
6
[Psychopharmacological profile of venlafaxine].[文拉法辛的精神药理学概况]
Encephale. 1999 Jun;25 Spec No 2:21-2; discussion 23-5.
7
Evidence of the dual mechanisms of action of venlafaxine.文拉法辛双重作用机制的证据。
Arch Gen Psychiatry. 2000 May;57(5):503-9. doi: 10.1001/archpsyc.57.5.503.
8
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.文拉法辛：体外对细胞色素P450 2D6依赖性丙咪嗪和地昔帕明代谢的抑制作用；与选定的选择性5-羟色胺再摄取抑制剂的比较研究，以及对人肝细胞色素P450 3A4、细胞色素P450 2C9和细胞色素P450 1A2的影响。
Br J Clin Pharmacol. 1997 Jun;43(6):619-26. doi: 10.1046/j.1365-2125.1997.00591.x.
9
Venlafaxine: a heterocyclic antidepressant.文拉法辛：一种杂环类抗抑郁药。
Am J Hosp Pharm. 1994 Dec 15;51(24):3033-46.
10
Effects of venlafaxine in the sleep architecture of rats.
Psychopharmacology (Berl). 1997 Feb;129(3):295-6. doi: 10.1007/s002130050194.
Zotero 插件